1. Home
  2. NVEE vs INDV Comparison

NVEE vs INDV Comparison

Compare NVEE & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVEE
  • INDV
  • Stock Information
  • Founded
  • NVEE 1949
  • INDV 1994
  • Country
  • NVEE United States
  • INDV United States
  • Employees
  • NVEE N/A
  • INDV N/A
  • Industry
  • NVEE Other Consumer Services
  • INDV Biotechnology: Pharmaceutical Preparations
  • Sector
  • NVEE Consumer Discretionary
  • INDV Health Care
  • Exchange
  • NVEE Nasdaq
  • INDV Nasdaq
  • Market Cap
  • NVEE 1.0B
  • INDV 1.2B
  • IPO Year
  • NVEE 2013
  • INDV N/A
  • Fundamental
  • Price
  • NVEE $19.34
  • INDV $11.08
  • Analyst Decision
  • NVEE Strong Buy
  • INDV Strong Buy
  • Analyst Count
  • NVEE 3
  • INDV 2
  • Target Price
  • NVEE $25.67
  • INDV $14.50
  • AVG Volume (30 Days)
  • NVEE 498.6K
  • INDV 939.2K
  • Earning Date
  • NVEE 05-01-2025
  • INDV 04-24-2025
  • Dividend Yield
  • NVEE N/A
  • INDV N/A
  • EPS Growth
  • NVEE N/A
  • INDV N/A
  • EPS
  • NVEE 0.45
  • INDV N/A
  • Revenue
  • NVEE $962,752,000.00
  • INDV $1,170,000,000.00
  • Revenue This Year
  • NVEE $10.70
  • INDV N/A
  • Revenue Next Year
  • NVEE $5.66
  • INDV $4.26
  • P/E Ratio
  • NVEE $43.18
  • INDV N/A
  • Revenue Growth
  • NVEE 8.74
  • INDV 4.09
  • 52 Week Low
  • NVEE $14.75
  • INDV $7.33
  • 52 Week High
  • NVEE $26.14
  • INDV $18.59
  • Technical
  • Relative Strength Index (RSI)
  • NVEE 65.09
  • INDV 56.35
  • Support Level
  • NVEE $18.14
  • INDV $10.91
  • Resistance Level
  • NVEE $19.08
  • INDV $12.26
  • Average True Range (ATR)
  • NVEE 0.78
  • INDV 0.47
  • MACD
  • NVEE 0.33
  • INDV 0.03
  • Stochastic Oscillator
  • NVEE 96.98
  • INDV 66.95

About NVEE NV5 Global Inc.

NV5 Global Inc is a provider of technology, conformity assessment, and consulting solutions to public and private sector clients in the infrastructure, utility services, construction, real estate, environmental, and geospatial markets, operating nationwide and abroad. The Company's clients include the U.S. Federal, state and local governments, and the private sector. The operating business segments are Infrastructure, Building, Technology & Sciences, and Geospatial Solutions. The maximum revenue derives from the infrastructure segment.

About INDV Indivior PLC

Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.

Share on Social Networks: